References
- Raghu P, Sivakumar B. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis. Biochim Biophys Acta. 2004;1703:1–9.
- Newcomer ME, Ong DE. Plasma retinol binding protein: structure and function of the prototypic lipocalin. Biochim Biophys Acta. 2000;1482:57–64.
- Moise AR, Noy N, Palczewski K, Blaner WS. Delivery of retinoid-based therapies to target tissues. Biochemistry. 2007;46:4449–58.
- Noy N. Retinoid-binding proteins: mediators of retinoid action. Biochem J. 2000;348:481–95.
- Kuvibidila S, Yu L, Gardner R, Velez M, Ode D, Warrier RP. Association between increased levels of TNF-alpha, decreased levels of prealbumin and retinol-binding protein, and disease outcome. J Natl Med Assoc. 2000;92:485–91.
- Uderzo C, Rovelli A, Bonomi M, Barzaghi A, Strada S, Balduzzi A, et al. Nutritional status in untreated children with acute leukemia as compared with children without malignancy. J Pediatr Gastroenterol Nutr. 1996;23:34–7.
- Bankson DD, Rifai N, Silverman LM. Immunoturbidimetric measurement of serum retinol-binding protein in renal and hepatic disease. Ann Clin Biochem. 1988;25:246–9.
- Shaffer LG, Slovak ML, Campbell LJ, editors. An international system for human cytogenetic nomenclature, ISCN. Basel: S. Krager; 2009.
- Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358:1909–18.
- Rulina AV, Spirin PV, Prassolov VS. Activated leukemic oncogenes AML1-ETO and c-kit: role in development of acute myeloid leukemia and current approaches for their inhibition. Biochemistry (Mosc). 2010;75:1650–66.
- Drescher T, Singler K, Ulrich A, Koller M, Keller U, Christ-Crain M, et al. Comparison of two malnutrition risk screening methods (MNA and NRS 2002) and their association with markers of protein malnutrition in geriatric hospitalized patients. Eur J Clin Nutr. 2010;64:887–93.
- Engle-Stone R, Haskell MJ, Ndjebayi AO, Nankap M, Erhardt JG, Gimou MM, et al. Plasma retinol-binding protein predicts plasma retinol concentration in both infected and uninfected Cameroonian women and children. J Nutr. 2011;141:2233–41.
- Rosales FJ, Ross AC. A low molar ratio of retinol binding protein to transthyretin indicates vitamin A deficiency during inflammation: studies in rats and a posterior analysis of vitamin A-supplemented children with measles. J Nutr. 1998;128:1681–7.
- Lawson ND, Berliner N. Neutrophil maturation and the role of retinoic acid. Exp Hematol. 1999;27:1355–67.
- Burnett AK, Hills RK, Milligan DW, Goldstone AH, Prentice AG, McMullin MF, et al. Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial. J Clin Oncol. 2010;28:586–95.
- Estey EH, Thall PF, Pierce S, Cortes J, Beran M, Kantarjian H, et al. Randomized phase II study of fludarabine+cytosine arabinoside+idarubicin +/− all-trans retinoic acid +/− granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome. Blood. 1999;93:2478–84.
- Schlenk RF, Fröhling S, Hartmann F, Fischer JT, Glasmacher A, del Valle F, et al. Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. Leukemia. 2004;18:1798–1803.